Copolymerized PEGlyated Acrylate Hydrogels for Delivery of Dicolofenac Sodium - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Copolymerized PEGlyated Acrylate Hydrogels for Delivery of Dicolofenac Sodium
Hydrogels are biocompatible drug delivery systems by which the physical properties can be controlled by the cross-linking density. Hydrogels were prepared by copolymerization of acrylic acid monomers in the presence of poly(ethylene glycol)(PEG) to form polyethylene diacrylate (PEDGA). Various molecular weights of PEGs were used for the synthesis of PEGDA to study the effect of molecular weight of PEG on the properties of hydrogels. These hydrogels were further characterized for free water, swelling..


Pharmaceutical Technology


As the prepared hydrogels were washed and dried before characterization, the type of polymerization technique used (bulk or solution polymerization) imparted no significant change in the physical properties of the hydrogels. The faster technique (the solution-polymerization method) was continued for further preparation of the hydrogels.


Figure 3
Radical polymerization was accomplished by exposing the polymerizing mixture (i.e., the aqueous solution containing the monomer and cross-linker) to UV radiation (365 nm) using a photochemical reactor (Jain Scientific Glasswares, Ambala, India) for 36 h. Completion of polymerization was evident from the change in the physical state of the reaction mixture. The reaction mixture initially was in the form of a liquid, which gradually thickened as the polymerization took place. A flexible solid mass was formed upon the completion of polymerization. In this way, the hydrogels were prepared using PEGDA of various molecular weights and in different weight ratios. PEGDA, being a bifunctional agent, can serve as a cross-linker in the present copolymerization reaction (see Figure 3).


Figure 4
As the molecular weight of the cross-linker is increased, the molar percentage will decrease for the same weight percentage. With the increase in the molecular weight of PEGDA, therefore, the cross-link density would decrease. This change follows the prediction made by the chemical representation of the copolymeric PEG-acrylate hydrogels containing PEGDA of different molecular weights (see Figure 4). It is assumed that for the same molar ratio of PEGDA, the size of the pores might increase with the increase in molecular weight.

Purification and drying of hydrogels . The polymerization was done until a solid mass was formed that may contain some unreacted monomers, either entrapped in the matrix or adsorbed on the surface. Purification of the hydrogels that were formed was essential before their further use. The purification was carried out by soaking the prepared hydrogels in a hydroalcoholic mixture for 24 h. The acrylate monomers, being soluble in water, came out in the aqueous system used for washing. The washing medium was tested intermittently for the presence of any extractive by spectral analysis by scanning in the UV range against a suitable blank. Completion of purification was confirmed by the absence of any absorbance in this range.

Swollen hydrogels have lower mechanical strength and further provide surface for microbial growth. The purified hydrogels were dried to help in their further handling and storage. Drying was performed under hot-air stream flowing over the hydrogel surface using a hot-air sterilizer oven for 2 h at 60 °C, followed by 2 h of drying in a vacuum oven at 45 °C. The two steps for drying were followed because fast drying in a vacuum oven can create a dried, glassy shell around the hydrogel's surface, which can considerably slow down the drying process. Air-drying, therefore, is done because it can uniformly remove the moisture without creating a dried, glassy shell around the hydrogel's surface. A major portion (approximately 70–80%) of the moisture can be removed by air-drying. After this initial drying, the residual moisture (i.e., the remaining 20–30%) can be removed effectively with a vacuum oven (30).


ADVERTISEMENT

RELATED CONTENT
Roche Recalls Viracept
Copolymerized PEGlyated Acrylate Hydrogels for Delivery of Dicolofenac Sodium
The Effect of Core and Coating Composition on Drug Release from Directly Compressed Time-Controlled Release Tablets
Near-Infrared Assay and Content Uniformity of Tablets
Maintain Your Moving Parts
blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What is the single greatest threat to maintaining manufacturing processes at your facility?
Quality issues
Facility/environment problems
Process development problems
Production equipment downtime
Raw material supply problems
Regulatory restrictions
Business decisions to limit production
Quality issues
50%
Facility/environment problems
0%
Process development problems
0%
Production equipment downtime
17%
Raw material supply problems
17%
Regulatory restrictions
0%
Business decisions to limit production
17%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Patent Settlements Become More Risky
Praise and Perils for Biotechnology Patent Policy
Risk-Mitigation Strategies in Drug Manufacturing for Emerging Markets
Quality Focus: Ensuring Raw Material Transparency
Advertising of Prescription Drugs  Keeping it Honest and Balanced
Source: Pharmaceutical Technology,
Click here